KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based CompensationShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Thermo Fisher Scientific (TMO) Short-Term Debt issuances (2016 - 2023)

Thermo Fisher Scientific (TMO) has disclosed Short-Term Debt issuances for 15 consecutive years, with $593.0 million as the latest value for Q3 2023.

  • For the quarter ending Q3 2023, Short-Term Debt issuances rose 46.06% year-over-year to $593.0 million, compared with a TTM value of $593.0 million through Mar 2024, down 69.23%, and an annual FY2025 reading of $1.1 billion, changed N/A over the prior year.
  • Short-Term Debt issuances was $593.0 million for Q3 2023 at Thermo Fisher Scientific, down from $1.0 billion in the prior quarter.
  • Across five years, Short-Term Debt issuances topped out at $2.5 billion in Q4 2021 and bottomed at $1.0 million in Q2 2020.
  • Average Short-Term Debt issuances over 5 years is $678.6 million, with a median of $406.0 million recorded in 2022.
  • Peak annual rise in Short-Term Debt issuances hit 282.0% in 2020, while the deepest fall reached 99.94% in 2020.
  • Year by year, Short-Term Debt issuances stood at $200.0 million in 2019, then crashed by 99.5% to $1.0 million in 2020, then skyrocketed by 251100.0% to $2.5 billion in 2021, then crashed by 88.26% to $295.0 million in 2022, then skyrocketed by 101.02% to $593.0 million in 2023.
  • Business Quant data shows Short-Term Debt issuances for TMO at $593.0 million in Q3 2023, $1.0 billion in Q2 2023, and $295.0 million in Q4 2022.